Archive for 2004

Foresight or folly? Generics firms’ foray into NCEs

Foresight or folly? Generics firms’ foray into NCEs A number of generics firms have, over the last few years, veered off the path and started to develop innovative drugs in their own right. In a time when generics firms are showing the greatest growth in the pharmaceutical sector, what has driven them to venture into […]


How many trillions for a drug miracle?

How many trillions for a drug miracle? “Here’s a quick thought experiment about the current system for developing and paying for miracle drugs: Would it be worth almost any price to develop a drug with a better than 50-50 probability of conquering many of the world’s most deadly diseases? “


Biotechblog